Prescription Tadalafil tablets recalled for manufacturing process deviations
Preferred Pharmaceuticals is recalling 32 bottles of Tadalafil 20 mg tablets due to manufacturing process deviations identified during FDA inspection. The recalled lots expire January 31, 2024.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for manufacturing process deviations without reported illnesses or injuries. No specific contamination or defect is identified, classifying this as a precautionary recall.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling 32 bottles of Tadalafil 20 mg tablets distributed nationwide. The affected lots are C0822E, F1121B, and G2721L, all with an expiration date of January 31, 2024.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations discovered at the manufacturing facility (Accord Healthcare) following an FDA inspection. cGMP compliance ensures the safety, purity, and quality of pharmaceutical products. The specific nature of the manufacturing deviations is not detailed in the recall notice.
Patients currently taking this medication should not stop without consulting their healthcare provider. Individuals with affected lots should contact their pharmacy or doctor to determine if their supply is involved and to arrange an alternative source if needed.
For more information, consumers may contact the FDA's division of drug safety or speak with their healthcare provider or pharmacist.
The recalled product
- Product
- TADALAFIL (TADALAFIL)
- Brand
- TADALAFIL
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug
- Hazard
- manufacturing-deviation
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot: C0822E
- Exp 1/31/2024
- F1121B
- G2721L
- Exp 1/31/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TADALAFIL
- ModerateTadalafil Tablets 20 mg recalled due to manufacturing deviations
FDA (Drugs) · 2023-05-03
- HighTadalafil Tablets Recalled Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-05-03
- ModerateTadalafil tablets recalled due to manufacturing process deviations
FDA (Drugs) · 2023-03-08
- HighTadalafil tablets recalled for manufacturing quality control deviations
FDA (Drugs) · 2023-03-08
- HighTadalafil Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27